Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

ATOPIC DERMATITIS: MELATONIN AS POTENTIAL TREATMENT.

Marseglia L, Cuppari C, Manti S, D'Angelo G, Salpietro C, Reiter RJ, Gitto E.

J Biol Regul Homeost Agents. 2015 Apr-Jun;29(2 Suppl 1):142-9.

PMID:
26634600
2.

ATOPIC DERMATITIS: EXPRESSION OF IMMUNOLOGICAL IMBALANCE.

Manti S, Chimenz R, Salpietro A, Colavita L, Pennisi P, Pidone C, Sturiale M, Arrigo T, Miraglia Del Giudice M, Salpietro C, Cuppari C.

J Biol Regul Homeost Agents. 2015 Apr-Jun;29(2 Suppl 1):13-7.

PMID:
26634582
3.

The atopic march: progression from atopic dermatitis to allergic rhinitis and asthma.

Zheng T, Yu J, Oh MH, Zhu Z.

Allergy Asthma Immunol Res. 2011 Apr;3(2):67-73. doi: 10.4168/aair.2011.3.2.67. Epub 2011 Feb 14.

4.

A novel, topical, nonsteroidal, TRPV1 antagonist, PAC-14028 cream improves skin barrier function and exerts anti-inflammatory action through modulating epidermal differentiation markers and suppressing Th2 cytokines in atopic dermatitis.

Lee JH, Choi CS, Bae IH, Choi JK, Park YH, Park M.

J Dermatol Sci. 2018 Apr 30. pii: S0923-1811(18)30204-4. doi: 10.1016/j.jdermsci.2018.04.017. [Epub ahead of print]

PMID:
29752146
5.

Melatonin in the skin: synthesis, metabolism and functions.

Slominski A, Tobin DJ, Zmijewski MA, Wortsman J, Paus R.

Trends Endocrinol Metab. 2008 Jan;19(1):17-24. Epub 2007 Dec 26. Review.

PMID:
18155917
6.

Patients with atopic dermatitis have attenuated and distinct contact hypersensitivity responses to common allergens in skin.

Correa da Rosa J, Malajian D, Shemer A, Rozenblit M, Dhingra N, Czarnowicki T, Khattri S, Ungar B, Finney R, Xu H, Zheng X, Estrada YD, Peng X, Suárez-Fariñas M, Krueger JG, Guttman-Yassky E.

J Allergy Clin Immunol. 2015 Mar;135(3):712-20. doi: 10.1016/j.jaci.2014.11.017. Epub 2015 Jan 10.

PMID:
25583101
7.

The structure and function of the epidermal barrier in patients with atopic dermatitis - treatment options. Part two.

Pelc J, Czarnecka-Operacz M, Adamski Z.

Postepy Dermatol Alergol. 2018 Apr;35(2):123-127. doi: 10.5114/ada.2018.75234. Epub 2018 Apr 24. Review.

8.

Atopic dermatitis: molecular mechanisms, clinical aspects and new therapeutical approaches.

Galli E, Cicconi R, Rossi P, Casati A, Brunetti E, Mancino G.

Curr Mol Med. 2003 Mar;3(2):127-38. Review.

PMID:
12630559
9.

Epidermal permeability barrier defects and barrier repair therapy in atopic dermatitis.

Lee HJ, Lee SH.

Allergy Asthma Immunol Res. 2014 Jul;6(4):276-87. doi: 10.4168/aair.2014.6.4.276. Epub 2014 Mar 21. Review.

10.

Atopic dermatitis.

Bieber T.

Ann Dermatol. 2010 May;22(2):125-37. doi: 10.5021/ad.2010.22.2.125. Epub 2010 May 17.

11.

The role of cytokines/chemokines in the pathogenesis of atopic dermatitis.

Yamanaka K, Mizutani H.

Curr Probl Dermatol. 2011;41:80-92. doi: 10.1159/000323299. Epub 2011 May 12. Review.

PMID:
21576949
12.

Does therapeutic intervention in atopic dermatitis normalize epidermal Notch deficiency?

Melnik BC.

Exp Dermatol. 2014 Oct;23(10):696-700. doi: 10.1111/exd.12460. Epub 2014 Jul 16. Review.

PMID:
24889007
13.

Chronically relapsing pruritic dermatitis in the rats treated as neonate with capsaicin; a potential rat model of human atopic dermatitis.

Back SK, Jeong KY, Li C, Lee J, Lee SB, Na HS.

J Dermatol Sci. 2012 Aug;67(2):111-9. doi: 10.1016/j.jdermsci.2012.05.006. Epub 2012 May 28.

PMID:
22721998
14.

Cellular and molecular mechanisms in atopic dermatitis.

Oyoshi MK, He R, Kumar L, Yoon J, Geha RS.

Adv Immunol. 2009;102:135-226. doi: 10.1016/S0065-2776(09)01203-6. Review.

PMID:
19477321
15.

Humoral and Cellular Autoreactivity to Epidermal Proteins in Atopic Dermatitis.

Navarrete-Dechent C, Pérez-Mateluna G, Silva-Valenzuela S, Vera-Kellet C, Borzutzky A.

Arch Immunol Ther Exp (Warsz). 2016 Dec;64(6):435-442. Epub 2016 May 4. Review.

PMID:
27147107
16.

Molecular biology of atopic dermatitis.

Mu Z, Zhao Y, Liu X, Chang C, Zhang J.

Clin Rev Allergy Immunol. 2014 Oct;47(2):193-218. doi: 10.1007/s12016-014-8415-1. Review.

PMID:
24715253
17.

Atopic dermatitis: immune deviation, barrier dysfunction, IgE autoreactivity and new therapies.

Furue M, Chiba T, Tsuji G, Ulzii D, Kido-Nakahara M, Nakahara T, Kadono T.

Allergol Int. 2017 Jul;66(3):398-403. doi: 10.1016/j.alit.2016.12.002. Epub 2017 Jan 2. Review.

18.

Atopic dermatitis induces the expansion of thymus-derived regulatory T cells exhibiting a Th2-like phenotype in mice.

Moosbrugger-Martinz V, Tripp CH, Clausen BE, Schmuth M, Dubrac S.

J Cell Mol Med. 2016 May;20(5):930-8. doi: 10.1111/jcmm.12806. Epub 2016 Mar 2.

19.

Recent Advances in Pharmacotherapeutic Paradigm of Mild to Recalcitrant Atopic Dermatitis.

Hussain Z, Sahudin S, Thu HE, Shuid AN, Bukhari SN, Kumolosasi E.

Crit Rev Ther Drug Carrier Syst. 2016;33(3):213-263. Review.

PMID:
27910751
20.

The role of innate immune signaling in the pathogenesis of atopic dermatitis and consequences for treatments.

Skabytska Y, Kaesler S, Volz T, Biedermann T.

Semin Immunopathol. 2016 Jan;38(1):29-43. doi: 10.1007/s00281-015-0544-y. Epub 2015 Nov 16. Review.

PMID:
26573298

Supplemental Content

Support Center